In summary, our study identified six central genes (G6PD, PKM, ENO3, PFKL, PGD, and TALDO1) differentially expressed in AD and T2DM patients, which are involved in key glucose metabolism pathways. The gene discussed is G6PD; the disease is type 2 diabetes mellitus.